Come up with a name for your new list and we'll add to it:
Celgene raised a round of funding on , . Investors include
Edelson Technology Partners.
Celgene (NASDAQ: CELG) is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and i…